BioInteractions
BioInteractions Multi-Phase Coatings and Commitment 2 Care Support
Quidel, a provider of rapid diagnostic testing solutions and cell-based virology assays, has received the CE mark for its Quidel molecular RT-PCR assay for human metapneumovirus.
Quidel, a provider of rapid diagnostic testing solutions and cell-based virology assays, has received the CE mark for its Quidel molecular RT-PCR assay for human metapneumovirus.
The RT-PCR tests will provide enhanced ease of use, reduced processing time and ready-to-use reagent configurations.
The announcement follows the notice of the European launch of Quidel’s first molecular diagnostic test, a RT-PCR test for Influenza A+B.
The human metapneumovirus assay is not available in the US.
BioInteractions Multi-Phase Coatings and Commitment 2 Care Support
High-Precision Motion Control Components and Systems
Medical Device, Product Development, and Manufacturing Services